Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin.

Orlando F, Paolini C, Agarbati S, Tonnini C, Grieco A, Capelli C, Introna M, Provinciali M, Gabrielli A, Moroncini G.

J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/58922.

PMID:
31107440
2.

Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.

Golay J, Valgardsdottir R, Musaraj G, Giupponi D, Spinelli O, Introna M.

Blood. 2019 Mar 28;133(13):1395-1405. doi: 10.1182/blood-2018-07-864538. Epub 2019 Jan 17.

3.

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.

Rota C, Morigi M, Cerullo D, Introna M, Colpani O, Corna D, Capelli C, Rabelink TJ, Leuning DG, Rottoli D, Benigni A, Zoja C, Remuzzi G.

Stem Cell Res Ther. 2018 Aug 14;9(1):220. doi: 10.1186/s13287-018-0960-8.

4.

Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors.

Golay J, Martinelli S, Alzani R, Cribioli S, Albanese C, Gotti E, Pasini B, Mazzanti B, Saccardi R, Rambaldi A, Introna M.

Cytotherapy. 2018 Aug;20(8):1077-1088. doi: 10.1016/j.jcyt.2018.06.003. Epub 2018 Aug 7.

PMID:
30093325
5.

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.

Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, Introna M, Bukauskas A, Le Blanc K, Apperley J, Roelofs H, Van Campenhout A, Beguin Y, Kuball J, Lazzari L, Avanzini MA, Fibbe W, Chabannon C, Bonini C, Dazzi F.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2365-2370. doi: 10.1016/j.bbmt.2018.07.015. Epub 2018 Jul 20.

6.

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Perico N, Casiraghi F, Todeschini M, Cortinovis M, Gotti E, Portalupi V, Mister M, Gaspari F, Villa A, Fiori S, Introna M, Longhi E, Remuzzi G.

Front Immunol. 2018 Jun 14;9:1359. doi: 10.3389/fimmu.2018.01359. eCollection 2018.

7.

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.

Moroncini G, Paolini C, Orlando F, Capelli C, Grieco A, Tonnini C, Agarbati S, Mondini E, Saccomanno S, Goteri G, Svegliati Baroni S, Provinciali M, Introna M, Del Papa N, Gabrielli A.

PLoS One. 2018 Jun 1;13(6):e0196048. doi: 10.1371/journal.pone.0196048. eCollection 2018.

8.

Disposal of the residual autologous HSC units: Results of a survey carried out two years after the publication of a national policy in Italy.

Perseghin P, Laszlò D, Bonifazi F, Introna M, Accorsi P, Petrini C, Lombardini L.

Transfus Apher Sci. 2018 Apr;57(2):197-200. doi: 10.1016/j.transci.2018.01.007. Epub 2018 Jan 31. No abstract available.

PMID:
29402635
9.

Innovative Clinical Perspectives for CIK Cells in Cancer Patients.

Introna M, Correnti F.

Int J Mol Sci. 2018 Jan 25;19(2). pii: E358. doi: 10.3390/ijms19020358. Review.

10.

Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance.

Golay J, Pedrini O, Capelli C, Gotti E, Borleri G, Magri M, Vailati F, Passera M, Farina C, Rambaldi A, Introna M.

Cytotherapy. 2018 Feb;20(2):262-270. doi: 10.1016/j.jcyt.2017.11.009. Epub 2017 Dec 12.

PMID:
29246649
11.

Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.

Sironi F, Vallarola A, Violatto MB, Talamini L, Freschi M, De Gioia R, Capelli C, Agostini A, Moscatelli D, Tortarolo M, Bigini P, Introna M, Bendotti C.

Stem Cell Res. 2017 Dec;25:166-178. doi: 10.1016/j.scr.2017.11.005. Epub 2017 Nov 10.

12.

International Forum on GMP-grade human platelet lysate for cell propagation: summary.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, Lόpez-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2018 Jan;113(1):80-87. doi: 10.1111/vox.12593. Epub 2017 Oct 26. No abstract available.

PMID:
29076169
13.

International Forum on GMP-grade human platelet lysate for cell propagation.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, López-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2018 Jan;113(1):e1-e25. doi: 10.1111/vox.12594. Epub 2017 Oct 25. No abstract available.

PMID:
29071726
14.

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function.

Perico L, Morigi M, Rota C, Breno M, Mele C, Noris M, Introna M, Capelli C, Longaretti L, Rottoli D, Conti S, Corna D, Remuzzi G, Benigni A.

Nat Commun. 2017 Oct 17;8(1):983. doi: 10.1038/s41467-017-00937-2.

15.

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.

Introna M, Lussana F, Algarotti A, Gotti E, Valgardsdottir R, Micò C, Grassi A, Pavoni C, Ferrari ML, Delaini F, Todisco E, Cavattoni I, Deola S, Biagi E, Balduzzi A, Rovelli A, Parma M, Napolitano S, Sgroi G, Marrocco E, Perseghin P, Belotti D, Cabiati B, Gaipa G, Golay J, Biondi A, Rambaldi A.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2070-2078. doi: 10.1016/j.bbmt.2017.07.005. Epub 2017 Jul 13.

16.

CIK as therapeutic agents against tumors.

Introna M.

J Autoimmun. 2017 Dec;85:32-44. doi: 10.1016/j.jaut.2017.06.008. Epub 2017 Jul 2. Review.

PMID:
28679475
17.

The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies.

Golay J, Ubiali G, Introna M.

Haematologica. 2017 Oct;102(10):e400-e403. doi: 10.3324/haematol.2017.169334. Epub 2017 Jun 22. No abstract available.

18.

Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies.

Valgardsdottir R, Cattaneo I, Klein C, Introna M, Figliuzzi M, Golay J.

Blood. 2017 May 11;129(19):2636-2644. doi: 10.1182/blood-2016-08-735605. Epub 2017 Mar 13.

19.

Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis.

Capelli C, Zaccara E, Cipriani P, Di Benedetto P, Maglione W, Andracco R, Di Luca G, Pignataro F, Giacomelli R, Introna M, Vitali C, Del Papa N.

Cell Transplant. 2017 May 9;26(5):841-854. doi: 10.3727/096368917X694822. Epub 2017 Jan 31.

20.

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF.

Belotti D, Capelli C, Resovi A, Introna M, Taraboletti G.

Matrix Biol. 2016 Sep;55:106-116. doi: 10.1016/j.matbio.2016.03.003. Epub 2016 Mar 16.

PMID:
26992552
21.

Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories.

Gaipa G, Introna M, Golay J, Nolli ML, Vallanti G, Parati E, Giordano R, Romagnoli L, Melazzini M, Biondi A, Biagi E.

Cytotherapy. 2016 Apr;18(4):481-6. doi: 10.1016/j.jcyt.2016.01.002.

PMID:
26971677
22.

First Report of a Successful Pregnancy in an Everolimus-Treated Heart-Transplanted Patient: Neonatal Disappearance of Immunosuppressive Drugs.

Fiocchi R, D'Elia E, Vittori C, Sebastiani R, Strobelt N, Eleftheriou G, Introna M, Freddi C, Crippa A.

Am J Transplant. 2016 Apr;16(4):1319-22. doi: 10.1111/ajt.13514. Epub 2015 Nov 10.

23.

Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of Amyotrophic Lateral Sclerosis.

Violatto MB, Santangelo C, Capelli C, Frapolli R, Ferrari R, Sitia L, Tortarolo M, Talamini L, Previdi S, Moscatelli D, Salmona M, Introna M, Bendotti C, Bigini P.

Stem Cell Res. 2015 Jul;15(1):243-53. doi: 10.1016/j.scr.2015.06.010. Epub 2015 Jun 27.

24.

Clinical grade expansion of MSCs.

Capelli C, Pedrini O, Valgardsdottir R, Da Roit F, Golay J, Introna M.

Immunol Lett. 2015 Dec;168(2):222-7. doi: 10.1016/j.imlet.2015.06.006. Epub 2015 Jun 17.

PMID:
26092523
25.

Effects on membrane lung gas exchange of an intermittent high gas flow recruitment maneuver: preliminary data in veno-venous ECMO patients.

Castagna L, Zanella A, Scaravilli V, Magni F, Deab SA, Introna M, Mojoli F, Grasselli G, Pesenti A, Patroniti N.

J Artif Organs. 2015 Sep;18(3):213-9. doi: 10.1007/s10047-015-0831-3. Epub 2015 Mar 26.

PMID:
25809452
26.

Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extracts.

Papadimou E, Morigi M, Iatropoulos P, Xinaris C, Tomasoni S, Benedetti V, Longaretti L, Rota C, Todeschini M, Rizzo P, Introna M, Grazia de Simoni M, Remuzzi G, Goligorsky MS, Benigni A.

Stem Cell Reports. 2015 Apr 14;4(4):685-98. doi: 10.1016/j.stemcr.2015.02.002. Epub 2015 Mar 5.

27.

Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.

Todeschi MR, El Backly R, Capelli C, Daga A, Patrone E, Introna M, Cancedda R, Mastrogiacomo M.

Stem Cells Dev. 2015 Jul 1;24(13):1570-81. doi: 10.1089/scd.2014.0490. Epub 2015 Mar 18.

28.

Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease: successes and hurdles.

Introna M, Rambaldi A.

Curr Opin Organ Transplant. 2015 Feb;20(1):72-8. doi: 10.1097/MOT.0000000000000158. Review.

PMID:
25563994
29.

In vivo model for mastocytosis: A comparative review.

Ranieri G, Marech I, Pantaleo M, Piccinno M, Roncetti M, Mutinati M, Rizzo A, Gadaleta CD, Introna M, Patruno R, Sciorsci RL.

Crit Rev Oncol Hematol. 2015 Mar;93(3):159-69. doi: 10.1016/j.critrevonc.2014.10.010. Epub 2014 Oct 31. Review.

PMID:
25465741
30.

Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.

Da Roit F, Engelberts PJ, Taylor RP, Breij EC, Gritti G, Rambaldi A, Introna M, Parren PW, Beurskens FJ, Golay J.

Haematologica. 2015 Jan;100(1):77-86. doi: 10.3324/haematol.2014.107011. Epub 2014 Oct 24.

31.

A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy.

Golay J, D'Amico A, Borleri G, Bonzi M, Valgardsdottir R, Alzani R, Cribioli S, Albanese C, Pesenti E, Finazzi MC, Quaresmini G, Nagorsen D, Introna M, Rambaldi A.

J Immunol. 2014 Nov 1;193(9):4739-47. doi: 10.4049/jimmunol.1401550. Epub 2014 Sep 29.

32.

Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells.

Valgardsdottir R, Capitanio C, Texido G, Pende D, Cantoni C, Pesenti E, Rambaldi A, Golay J, Introna M.

Exp Hematol. 2014 Dec;42(12):1013-21.e1. doi: 10.1016/j.exphem.2014.08.005. Epub 2014 Sep 6.

PMID:
25201755
33.

Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.

Rambaldi A, Biagi E, Bonini C, Biondi A, Introna M.

Leukemia. 2015 Jan;29(1):1-10. doi: 10.1038/leu.2014.189. Epub 2014 Jun 12. Review.

PMID:
24919807
34.

c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.

Patruno R, Marech I, Zizzo N, Ammendola M, Nardulli P, Gadaleta C, Introna M, Capriuolo G, Rubini RA, Ribatti D, Gadaleta CD, Ranieri G.

Biomed Res Int. 2014;2014:730246. doi: 10.1155/2014/730246. Epub 2014 May 12.

35.

Low-fiber alfalfa (Medicago sativa L.) meal in the laying hen diet: effects on productive traits and egg quality.

Laudadio V, Ceci E, Lastella NM, Introna M, Tufarelli V.

Poult Sci. 2014 Jul;93(7):1868-74. doi: 10.3382/ps.2013-03831. Epub 2014 May 26.

PMID:
24864286
36.

Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols.

Capelli C, Pedrini O, Cassina G, Spinelli O, Salmoiraghi S, Golay J, Rambaldi A, Giussani U, Introna M.

Haematologica. 2014 Jun;99(6):e94-7. doi: 10.3324/haematol.2014.104711. Epub 2014 Mar 28. No abstract available.

37.

A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel.

Perseghin P, Marchetti M, Pierelli L, Olivieri A, Introna M, Lombardini L, Accorsi P, Petrini C, Risso M, Bosi A; Società Italiana di Emaferesi e Manipolazione Cellulare,; Gruppo Italiano Trapianto Midollo Osseo; Centro Nazionale Trapianti.

Transfusion. 2014 Sep;54(9):2353-60. doi: 10.1111/trf.12619. Epub 2014 Mar 24.

PMID:
24654567
38.

Masitinib (AB1010), from canine tumor model to human clinical development: where we are?

Marech I, Patruno R, Zizzo N, Gadaleta C, Introna M, Zito AF, Gadaleta CD, Ranieri G.

Crit Rev Oncol Hematol. 2014 Jul;91(1):98-111. doi: 10.1016/j.critrevonc.2013.12.011. Epub 2013 Dec 17. Review.

PMID:
24405856
39.

Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line.

Verdelli D, Nobili L, Todoerti K, Mosca L, Fabris S, D'Anca M, Pellegrino E, Piva R, Inghirami G, Capelli C, Introna M, Baldini L, Chiaramonte R, Lombardi L, Neri A.

Genes Chromosomes Cancer. 2014 Feb;53(2):154-67. doi: 10.1002/gcc.22127. Epub 2013 Nov 5.

PMID:
24327544
40.

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, Balduzzi A, Longoni D, Pavan F, Masciocchi F, Algarotti A, Micò C, Grassi A, Deola S, Cavattoni I, Gaipa G, Belotti D, Perseghin P, Parma M, Pogliani E, Golay J, Pedrini O, Capelli C, Cortelazzo S, D'Amico G, Biondi A, Rambaldi A, Biagi E.

Biol Blood Marrow Transplant. 2014 Mar;20(3):375-81. doi: 10.1016/j.bbmt.2013.11.033. Epub 2013 Dec 7.

41.

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey.

Olivieri J, Pierelli L, Introna M, Accorsi P, Bosi A, Perseghin P, Risso M, Pandolfi A, Mancini S, Marchetti M, Dal Pozzo S, Gotti E, Rambaldi A, Leoni P, Olivieri A; Gitmo (Gruppo Italiano Trapianto di Midollo Osseo)–SIDEM (Società Italiana di Emaferesi e Manipolazione Cellulare) Working Group on SCU Disposal.

Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.

PMID:
24169075
42.

Influence of substituting dietary soybean for air-classified sunflower (Helianthus annuus L.) meal on egg production and steroid hormones in early-phase laying hens.

Laudadio V, Ceci E, Nahashon SN, Introna M, Lastella NM, Tufarelli V.

Reprod Domest Anim. 2014 Feb;49(1):158-63. doi: 10.1111/rda.12245. Epub 2013 Oct 18.

PMID:
24134610
43.

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.

Golay J, Da Roit F, Bologna L, Ferrara C, Leusen JH, Rambaldi A, Klein C, Introna M.

Blood. 2013 Nov 14;122(20):3482-91. doi: 10.1182/blood-2013-05-504043. Epub 2013 Oct 8.

44.

Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms.

Introna M, Golay J, Rambaldi A.

Immunol Lett. 2013 Sep-Oct;155(1-2):27-30. doi: 10.1016/j.imlet.2013.09.017. Epub 2013 Sep 29. Review.

PMID:
24084446
45.

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.

Franquesa M, Hoogduijn MJ, Reinders ME, Eggenhofer E, Engela AU, Mensah FK, Torras J, Pileggi A, van Kooten C, Mahon B, Detry O, Popp FC, Benseler V, Casiraghi F, Johnson C, Ancans J, Fillenberg B, delaRosa O, Aran JM, Roemeling-van Rhijn M, Pinxteren J, Perico N, Gotti E, Christ B, Reading J, Introna M, Deans R, Shagidulin M, Farré R, Rambaldi A, Sanchez-Fueyo A, Obermajer N, Pulin A, Dor FJ, Portero-Sanchez I, Baan CC, Rabelink TJ, Remuzzi G, Betjes MG, Dahlke MH, Grinyó JM; MiSOT Study Group.

Transplantation. 2013 Aug 15;96(3):234-8. doi: 10.1097/TP.0b013e318298f9fa. Erratum in: Transplantation. 2013 Sep;96(6):e49. Roemeling-vanRhijn, Marieke [corrected to Roemeling-van Rhijn, Marieke].

46.

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Noris M, Remuzzi G.

Transpl Int. 2013 Sep;26(9):867-78. doi: 10.1111/tri.12132. Epub 2013 Jun 6.

47.

The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.

Casolaro A, Golay J, Albanese C, Ceruti R, Patton V, Cribioli S, Pezzoni A, Losa M, Texido G, Giussani U, Marchesi F, Amboldi N, Valsasina B, Bungaro S, Cazzaniga G, Rambaldi A, Introna M, Pesenti E, Alzani R.

PLoS One. 2013;8(3):e58424. doi: 10.1371/journal.pone.0058424. Epub 2013 Mar 8.

48.

Suitability of partly destoned exhausted olive cake as by-product feed ingredient for lamb production.

Tufarelli V, Introna M, Cazzato E, Mazzei D, Laudadio V.

J Anim Sci. 2013 Feb;91(2):872-7. doi: 10.2527/jas.2012-5541. Epub 2012 Dec 10.

PMID:
23230122
49.

Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy.

Bologna L, Gotti E, Da Roit F, Intermesoli T, Rambaldi A, Introna M, Golay J.

J Immunol. 2013 Jan 1;190(1):231-9. doi: 10.4049/jimmunol.1202645. Epub 2012 Dec 5.

50.

Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2(V617F) myeloproliferative neoplasm patients.

Amaru Calzada A, Pedrini O, Finazzi G, Leoni F, Mascagni P, Introna M, Rambaldi A, Golay J; Associazione Italiana per la Ricerca sul Cancro-Gruppo Italiano Malattie Mieloproliferative Investigators.

Exp Hematol. 2013 Mar;41(3):253-60.e2. doi: 10.1016/j.exphem.2012.10.013. Epub 2012 Oct 27.

PMID:
23111067

Supplemental Content

Loading ...
Support Center